Log In
Register
Facebook icon
Instagram icon
Twitter X icon
LinkedIn icon
Business
Research
Treatments
News
Products
Multimedia
Site Map
2020
December
22
Defense Agency Awards $15M To Develop Skin Microbiome-based Mosquito Repellent
Nuvo Pharmaceuticals Rebrands as Miravo Healthcare
Intradermal Btx Forehead Injections as Effective as Intramuscular
Higher Reconstitution Volume of PLLA Offers Favorable Risk Benefit Ratio
Page 1 of 1